Open Access

[Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8

  • Authors:
    • Ting Liu
    • Jingjing Meng
    • Yu Zhang
  • View Affiliations

  • Published online on: July 22, 2021     https://doi.org/10.3892/mmr.2021.12312
  • Article Number: 673
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Mol Med Rep 22: [Related article:] 3316-3326, 2020, DOI: 10.3892/mmr.2020.11392

Following the publication of this paper, the authors have realized that they overlooked indicating that Ting Liu and Jingjing Meng contributed equally to this work. Therefore, the affiliations for this paper should have been written as follows:

TING LIU1*, JINGJING MENG2* and YU ZHANG3

Departments of 1Nuclear Medicine and 2Thyroid and Breast Surgery, The Affiliated Wuhan Central Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014; 3Department of Surgery II, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China

*Contributed equally

Furthermore, the authors have also realized that they overlooked acknowledging a source that contributed towards the paper's funding in the Funding section of the declarations. Accordingly, the following information should have been included in the paper regarding the funding received:

Funding

This work was partially supported by Shanghai Municipal Commission of Health and Family Planning (grant no. 201740175).

The authors confirm that there are no further errors in the study, and all the authors agree to this correction. The authors regret their oversight, and apologize for any inconvenience caused.

Related Articles

Journal Cover

September-2021
Volume 24 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu T, Meng J and Zhang Y: [Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8. Mol Med Rep 24: 673, 2021
APA
Liu, T., Meng, J., & Zhang, Y. (2021). [Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8. Molecular Medicine Reports, 24, 673. https://doi.org/10.3892/mmr.2021.12312
MLA
Liu, T., Meng, J., Zhang, Y."[Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8". Molecular Medicine Reports 24.3 (2021): 673.
Chicago
Liu, T., Meng, J., Zhang, Y."[Corrigendum] miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8". Molecular Medicine Reports 24, no. 3 (2021): 673. https://doi.org/10.3892/mmr.2021.12312